Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Mar 2023
Most studies used to examine small amounts of DNA in early human embryos do not involve gene therapy. As a result...
Read Full NewsEurope will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.
Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.
Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.
MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.
Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Clinical trial sees dramatic results using radiation to treat breast cancer
3.
Kate Middleton Reaches Cancer Treatment Milestone
4.
Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.
5.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
1.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
2.
Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights
3.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
4.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
5.
Transformative Advances in Hematology in Daily Practice
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
2.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge